Red eye. Ophthalmologist’s and General Practitioner’s point of view. Therapy with low-dose brimonidine Review article

Article Sidebar

PDF PDF (Język Polski)


Published: Oct 29, 2025
DOI: https://doi.org/10.24292/01.OT.001225
Keywords:
ocular redness, conjunctival hyperemia, brimonidine, tachyphylaxis, rebound effect

Main Article Content

Monika Udziela
1. Chair and Department of Ophthalmology, Faculty of Medicine, Medical University of Warsaw. 2. Independent Public Clinical Ophthalmology Hospital in Warsaw
http://orcid.org/0000-0001-5036-2091
Bartosz Sapilak
Department and Clinic of Family Medicine, Wroclaw Medical University
http://orcid.org/0000-0002-7999-5615

Abstract

Red eye is a symptom which may indicated different disorders. Mild hyperemia may occur without any defined aetiology and may cause esthetical and psychological problems for the patients. Diagnostics is crucial before implementing the symptomatic treatment to exclude any disease requiring targeted therapy. All cases of red eye symptom with pain and visual disturbances require special attention. Eyedrops with low-dose brimonidine are good alternative to other vasoconstrictors, as safe and well-tolerated medication not leading to hypoxia, tachyphylaxis and rebound effect.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Udziela M, Sapilak B. Red eye. Ophthalmologist’s and General Practitioner’s point of view. Therapy with low-dose brimonidine. Ophthatherapy [Internet]. 2025Oct.29 [cited 2026Apr.12];12(3):248-51. Available from: https://journalsmededu.pl/index.php/ophthatherapy/article/view/3447
Issue
Vol 12 No 3 (2025)
Section
Conservative treatment

Copyright: Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Vaidyanathan S, Williamson P, Clearie K et al. Fluticasone reverses oxymetazoline induced tachyphylaxis of response and rebound congestion. Am J Respir Crit Care Med. 2010; 182(1): 19-24. http://doi.org/10.1164/rccm.200911-1701OC.
2. Rahman MQ, Ramaesh K, Montgomery DM. Brimonidine for glaucoma. Expert Opin Drug Saf. 2010; 9(3): 483-91. http://doi.org/10.1517/14740331003709736.
3. Gupta A, Kekunnaya R, Sachdeva V et al. Strabismus surgery hemostasis. Ophthalmology. 2012; 119(3): 649-50. http://doi.org/10.1016/j.ophtha.2011.10.005.
4. Desco MC, Navea A, Ferrer E et al. Effect of prophylactic brimonidine on bleeding complications after cataract surgery. Eur J Ophthalmol. 2005; 15(2): 228-32.
5. Pasquali TA, Aufderheide A, Brinton JP et al. Dilute brimonidine to improve patient comfort and subconjunctival hemorrhage after LASIK. J Refract Surg. 2013; 29: 469-75. http://doi.org/10.3928/1081597X-20130617-05.
6. Kim CS, Nam KY, Kim JY. Effect of prophylactic topical brimonidine (0.15%) administration on the development of subconjunctival hemorrhage after intravitreal injection. Retina. 2011; 31(2): 389-92. http://doi.org/10.1097/IAE.0b013e3181eef28e.
7. Ackerman SL, Torkildsen GL, McLaurin E et al. Low-dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials. Clin Exp Optom. 2019; 102: 131-9.
8. McLaurin E, Cavet ME, Gomes PJ et al. Brimonidine ophthalmic solution 0.025% for reduction of ocular redness: a randomized clinical trial. Optom Vis Sci. 2018; 95: 264-71.
9. Nejad M, Lin SR, Hwang LH et al. Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults. Graefes Arch Clin Exp Ophthalmol. 2021; 259(11): 3333-8.
10. Ucar F, Cetinkaya S. The Results of Preoperative Topical Brimonidine Usage in Pterygium Surgery. J Ocul Pharmacol Ther. 2020; 36(4): 234-7. http://doi.org/10.1089/jop.2019.0085.